How long does Wegovy take to work for weight loss?

Wegovy (semaglutide 2.4mg) is titrated gradually over roughly 16 weeks before reaching the standard maintenance dose, this pacing reduces side effects, not results.
Appetite reduction is often the first change people notice, sometimes within the first one to two weeks at the starter dose.
Visible scale change usually appears from weeks four to eight onward, becoming more pronounced as the dose increases.
Clinical trial data at 68 weeks showed an average loss of approximately 15% body weight, the full benefit builds across months, not days.

Most people notice the first signs that Wegovy is working within the opening few weeks — but meaningful, sustained weight loss typically builds over several months of treatment. In clinical trials, participants using semaglutide 2.4mg lost an average of around 15% of their body weight over 68 weeks, according to the STEP 1 trial published in the New England Journal of Medicine. That timeline matters, because Wegovy is a prescription-only medicine and its effects are gradual by design. A GPhC-registered prescriber reviews every patient before it can be supplied — and understanding what to expect at each stage helps you set realistic expectations from day one.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What to expect at each stage of Wegovy treatment, and why the timeline is what it is

When do most people first feel Wegovy doing something?

The earliest signal is almost never weight on the scale, it is appetite. At the 0.25mg starter dose, many people report a quieter pull toward food, particularly between meals. Portions that once felt comfortable may start to feel like too much. That shift can arrive within the first seven to fourteen days, though not everyone notices it this soon, and the absence of it does not mean the medicine is not working.

What is happening biologically is that semaglutide is binding to GLP-1 receptors in the brain and gut, slowing gastric emptying and sending earlier satiety signals. The starter dose is deliberately low, its job is to let your body adjust, not to produce immediate results. If you want a detailed breakdown of how long Wegovy takes to work at each stage of the process, that is worth reading before your first injection. The titration schedule exists to protect you from the gastrointestinal side effects that arrive when the dose climbs too fast.

The NHS semaglutide medicines page confirms that nausea, which is the most frequently reported early side effect, generally settles within days to a couple of weeks of each dose step. Knowing that can make the adjustment period easier to sit through.

How much weight loss is realistic by weeks four to twelve?

By the time the dose reaches 0.5mg or 1.0mg (roughly weeks four to eight of treatment) the appetite suppression usually deepens and the first meaningful scale movement tends to follow. Studies suggest weight loss in this window is modest: a few kilograms is a reasonable and healthy pace. The body responds to a sustained calorie deficit, and that deficit grows as appetite continues to fall.

It is also worth knowing what the rate of early weight loss can realistically look like week by week, because the speed varies considerably between individuals. Factors including starting weight, dietary habits, activity level and how quickly side effects settle all shape the pace. A person with a higher starting BMI will often lose more in absolute kilograms early on, even if the percentage loss looks similar.

Some people experience a brief plateau between dose increases. This is normal. The body's energy regulation adapts, and the next dose step tends to restart progress. A prescriber can discuss this if it happens, it is not a signal to stop.

When does peak effect typically arrive, and what does the evidence say?

The STEP 1 trial ran for 68 weeks. Participants using semaglutide 2.4mg alongside lifestyle changes lost an average of around 15% of their body weight by the end, roughly 15.3kg from an average starting weight of just over 105kg. That is a lot of information packed into one sentence, so it is worth unpacking: the weight loss was not linear, and most of the total came in the second half of the trial as the full maintenance dose took effect.

At the 2.4mg maintenance dose, which most patients reach around week sixteen to twenty depending on tolerability, weight loss tends to accelerate. The NICE appraisal of semaglutide confirms these results and considers them clinically significant, noting that treatment should be reviewed if less than 5% weight loss has occurred after six months on the maintenance dose. That review threshold is a clinical checkpoint, not a failure, NICE's guidance on semaglutide (TA875) sets it out as part of responsible prescribing.

For context on how long Wegovy treatment typically continues and what happens at the end of a course, that is worth reading separately. The short answer is that NICE recommends a maximum of two years under specialist management on the NHS, private treatment plans are agreed individually with your prescriber.

What affects how quickly Wegovy works for you specifically?

The 15% average is just that, an average. Some people in the STEP 1 trial lost more than 20%; others lost less. Several factors influence where an individual lands. Adherence to the injection schedule is the clearest one: semaglutide works best when taken consistently each week. Dietary choices matter too, the medicine reduces appetite but does not override a diet high in ultra-processed foods, and protein adequacy supports muscle retention during weight loss.

Sleep quality, stress levels and physical activity all contribute to how efficiently the body uses the calorie deficit the medicine helps create. Our clinical team, led by our clinical lead, encourages patients to think of Wegovy, a once-weekly injectable treatment containing semaglutide, as a tool that makes the conditions for weight loss easier to maintain, not a replacement for the lifestyle changes that lock results in.

If you are curious about how long Wegovy weight loss takes to build into meaningful results, including what a realistic timeline looks like across the full course of treatment, our overview page sets that out clearly. And if you want a granular look at how long it takes for Wegovy to work across different dose stages, that companion guide covers the week-by-week picture in more detail. If you are ready to find out whether semaglutide is clinically appropriate for you, our prescribers are available seven days a week, speak to our prescribers to start your free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions